Literature DB >> 15702101

Methotrexate and oral ulceration.

G M J Deeming1, J Collingwood, M N Pemberton.   

Abstract

Methotrexate is well established in the drug treatment of various neoplastic diseases. More recently it has become increasingly used as a once-weekly, low-dose treatment of disorders such as psoriasis and rheumatoid arthritis. Clinical trials have shown its effectiveness in these conditions and it is likely that dentists will encounter patients taking this drug in general dental practice. Oral ulceration can occur as a side effect of methotrexate therapy. This may be due to lack of folic acid supplementation or overdosage due to confusion regarding its once-weekly regime. Illustrations of these problems, which have initially presented in a dental setting, are given. Important drug interactions of methotrexate relevant to dentistry are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15702101     DOI: 10.1038/sj.bdj.4811972

Source DB:  PubMed          Journal:  Br Dent J        ISSN: 0007-0610            Impact factor:   1.626


  11 in total

Review 1.  Oral pathology in inflammatory bowel disease.

Authors:  Miranda Muhvić-Urek; Marija Tomac-Stojmenović; Brankica Mijandrušić-Sinčić
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Anti-Toxoplasma antibodies in Egyptian rheumatoid arthritis patients.

Authors:  Abeer A El-Henawy; Eman Abdel Razek Hafez; Nairmen Nabih; Naglaa M Shalaby; Mervat Mashaly
Journal:  Rheumatol Int       Date:  2017-03-20       Impact factor: 2.631

Review 3.  Managing Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care Practitioners.

Authors:  April W Armstrong; Lakshi Aldredge; Paul S Yamauchi
Journal:  J Cutan Med Surg       Date:  2015-12-28       Impact factor: 2.092

4.  Age-related Epstein-Barr virus-positive cutaneous ulcer arising after a self-limited subcutaneous abscess: a case report.

Authors:  Shemsedin Sadiku; Fisnik Kurshumliu; Xhevdet Krasniqi; Ahmet Brovina; Emrush Kryeziu; Ibrahim Rrudhani; Kastriot Meqa; Lumturije Gashi-Luci; Hartmut Merz
Journal:  J Med Case Rep       Date:  2012-09-11

Review 5.  Relationship between Periodontitis and Rheumatoid Arthritis: Review of the Literature.

Authors:  Vilana Maria Adriano Araújo; Iracema Matos Melo; Vilma Lima
Journal:  Mediators Inflamm       Date:  2015-08-04       Impact factor: 4.711

6.  Oral manifestations of T-cell large granular lymphocytic leukemia: a case report.

Authors:  Ioanna-Eirini Arvanitidou; Nikolaos G Nikitakis; Alexandra Sklavounou
Journal:  J Oral Maxillofac Res       Date:  2011-10-01

7.  Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature.

Authors:  Toni K Roberts; Xueyan Chen; Jay Justin Liao
Journal:  Exp Hematol Oncol       Date:  2016-04-27

8.  Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery.

Authors:  Pasquale Linciano; Alice Dawson; Ina Pöhner; David M Costa; Monica S Sá; Anabela Cordeiro-da-Silva; Rosaria Luciani; Sheraz Gul; Gesa Witt; Bernhard Ellinger; Maria Kuzikov; Philip Gribbon; Jeanette Reinshagen; Markus Wolf; Birte Behrens; Véronique Hannaert; Paul A M Michels; Erika Nerini; Cecilia Pozzi; Flavio di Pisa; Giacomo Landi; Nuno Santarem; Stefania Ferrari; Puneet Saxena; Sandra Lazzari; Giuseppe Cannazza; Lucio H Freitas-Junior; Carolina B Moraes; Bruno S Pascoalino; Laura M Alcântara; Claudia P Bertolacini; Vanessa Fontana; Ulrike Wittig; Wolfgang Müller; Rebecca C Wade; William N Hunter; Stefano Mangani; Luca Costantino; Maria P Costi
Journal:  ACS Omega       Date:  2017-09-11

Review 9.  Linkage of Periodontitis and Rheumatoid Arthritis: Current Evidence and Potential Biological Interactions.

Authors:  Rafael Scaf de Molon; Carlos Rossa; Rogier M Thurlings; Joni Augusto Cirelli; Marije I Koenders
Journal:  Int J Mol Sci       Date:  2019-09-13       Impact factor: 5.923

10.  Methotrexate enhances antigen presentation and maturation of tumour antigen-loaded dendritic cells through NLRP3 inflammasome activation: a strategy for dendritic cell-based cancer vaccine.

Authors:  Gao-Na Shi; Min Hu; Chengjuan Chen; Junmin Fu; Shuai Shao; Yu Zhou; Lei Wu; Tiantai Zhang
Journal:  Ther Adv Med Oncol       Date:  2021-01-21       Impact factor: 8.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.